Cartherics
PrivateLast Round
Series C
Oct 1, 2024
Total Funding Raised
$20.55M
Company Overview
Cartherics is a biotechnology company that develops off-the-shelf immune cell therapies for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cartherics Comparables
Compare Cartherics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iCamuno Biotherapeutics | 84% | |
| Shoreline Biosciences | 82% | |
| Neukio Biotherapeutics | 82% |
Cartherics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 1, 2024 | ||||
| Grant | Sep 27, 2022 | ||||
| Grant | Jul 28, 2020 | ||||
| Series C | Aug 21, 2019 | ||||
| Grant | Dec 22, 2017 |
Key People
Founding team and executive leadership
Cartherics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Monash University | Grant |
| Hudson Institute of Medical Research | Grant |
| Entrepreneurs' Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 44% MoM.
- Jul 2, 2025
Monthly visitors increased 148% MoM, reaching 5.7K.
Cartherics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cartherics's valuation, stock price, and market status.
Is Cartherics a public or private company?
Cartherics is a private company.
What is the current stock price of Cartherics?
Cartherics is a private company with no public stock price. No recent secondary market data is available.
How much is Cartherics worth (valuation)?
Valuation information for Cartherics is not publicly available.
Can I buy Cartherics stock?
Cartherics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cartherics's last funding round?
Cartherics's most recent funding round was Series C on October 1, 2024.
Who are the main investors in Cartherics?
Key investors in Cartherics include Monash University, Hudson Institute of Medical Research, Entrepreneurs' Programme.
Will Cartherics IPO soon?
No public IPO plans have been announced for Cartherics.
How can I track Cartherics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cartherics's secondary market activity and sign up for updates.